FDA Approves a New HER2-targeted Therapeutic for Breast Cancer
Earlier this week, the U.S. Food and Drug Administration (FDA) approved a new molecularly targeted therapeutic called neratinib (Nerlynx)...
Tag: FDA
Earlier this week, the U.S. Food and Drug Administration (FDA) approved a new molecularly targeted therapeutic called neratinib (Nerlynx)...
Hot on the heels of the FDA’s landmark approval of an anticancer therapeutic for use based on whether a...
Tuesday marked a milestone for the oncology community: The U.S. Food and Drug Administration (FDA) announced its first approval...
At the end of last week, the U.S. Food and Drug Administration (FDA) approved expanding the use of pembrolizumab...
This time last year there were no immune checkpoint inhibitors approved by the U.S. Food and Drug Administration (FDA)...
Last week, a flurry of U.S. Food and Drug Administration (FDA) oncology approvals concluded with the approval of the...
Earlier this week, the U.S. Food and Drug Administration (FDA) announced that it had approved a new immune checkpoint...
At the end of last week, the U.S. Food and Drug Administration (FDA) announced the approval of the first...
On Thursday, the U.S. Food and Drug Administration (FDA) expanded the use of the antiangiogenic therapeutic regorafenib (Stivarga) to...
On March 23, the U.S. Food and Drug Administration announced the first-ever approval of a treatment for patients with...